» Articles » PMID: 27466237

Patterns of Weight Change After the Diagnosis of Type 2 Diabetes in Scotland and Their Relationship with Glycaemic Control, Mortality and Cardiovascular Outcomes: a Retrospective Cohort Study

Overview
Journal BMJ Open
Specialty General Medicine
Date 2016 Jul 29
PMID 27466237
Citations 32
Authors
Affiliations
Soon will be listed here.
Abstract

Objectives: To determine weight change patterns in Scottish patients 2 years after diagnosis of type 2 diabetes and to examine these in association with medium-term glycaemic, mortality and cardiovascular outcomes.

Setting: Using a retrospective cohort design, ethical approval was obtained to link the Scottish diabetes care database to hospital admission and mortality records.

Participants: 29 316 overweight/obese patients with incident diabetes diagnosed between 2002 and 2006 were identified with relevant information for ≥2 years.

Primary And Secondary Outcome Measures: Weight records over time provided intrapatient weight change and variation and glycated haemoglobin (HbA1c) gave measures of glycaemic control. These characteristics and demographic variables at diagnosis were linked with notifications of death (2-5 years after diagnosis) and cardiovascular events (0-5 year after diagnosis).

Results: By 2 years, 36% of patients had lost ≥2.5% of their weight. Increasing age, being female and a higher body mass index at diagnosis were associated with larger proportions of weight lost (p<0.001). Multivariable modelling showed that inadequate glycaemic control at 2 years was associated with being younger at baseline, being male, having lower levels of obesity at diagnosis, gaining weight or being weight stable with weight change variability, and starting antidiabetic medication. While weight change itself was not related to mortality or cardiovascular outcomes, major weight variability was independently associated with poorer survival and increased cardiovascular outcome risks, as was deprivation.

Conclusions: Our results suggest that weight loss or being weight stable with little weight variability early after diabetes diagnosis, are associated with better glycaemic control and we identified groups less able to lose weight. With respect to mortality and cardiovascular outcomes, although weight change at 2 years was a weak predictor, major weight variability appeared to be the more relevant factor.

Citing Articles

Type 2 Diabetes Incidence and Mortality: Associations with Physical Activity, Fitness, Weight Loss, and Weight Cycling.

Gaesser G Rev Cardiovasc Med. 2024; 23(11):364.

PMID: 39076198 PMC: 11269068. DOI: 10.31083/j.rcm2311364.


BMI variability and cardiovascular outcomes within clinical trial and real-world environments in type 2 diabetes: an IMI2 SOPHIA study.

Massey R, Chen Y, Panova-Noeva M, Mattheus M, Siddiqui M, Schloot N Cardiovasc Diabetol. 2024; 23(1):256.

PMID: 39014446 PMC: 11253469. DOI: 10.1186/s12933-024-02299-8.


Weight Change and the Risk of Micro and Macro Vascular Complications of Diabetes: A Systematic Review.

Sadat Rafiei S, Fateh F, Arab M, Espanlo M, Dahaghin S, Gilavand H Malays J Med Sci. 2024; 31(3):18-31.

PMID: 38984251 PMC: 11229574. DOI: 10.21315/mjms2024.31.3.2.


Trajectories of BMI before and after diagnosis of type 2 diabetes in a real-world population.

Donnelly L, McCrimmon R, Pearson E Diabetologia. 2024; 67(10):2236-2245.

PMID: 38967665 PMC: 11446948. DOI: 10.1007/s00125-024-06217-1.


Glycemic Control and Obesity Among People With Type 2 Diabetes in Europe and Australia: A Retrospective Cohort Analysis.

Newson R, Divino V, Boye K, Chen J, DeKoven M, Vallarino C Diabetes Ther. 2024; 15(6):1435-1449.

PMID: 38683494 PMC: 11096291. DOI: 10.1007/s13300-024-01583-w.


References
1.
Lindstrom J, Ilanne-Parikka P, Peltonen M, Aunola S, Eriksson J, Hemio K . Sustained reduction in the incidence of type 2 diabetes by lifestyle intervention: follow-up of the Finnish Diabetes Prevention Study. Lancet. 2006; 368(9548):1673-9. DOI: 10.1016/S0140-6736(06)69701-8. View

2.
Uusitupa M, Peltonen M, Lindstrom J, Aunola S, Ilanne-Parikka P, Keinanen-Kiukaanniemi S . Ten-year mortality and cardiovascular morbidity in the Finnish Diabetes Prevention Study--secondary analysis of the randomized trial. PLoS One. 2009; 4(5):e5656. PMC: 2682577. DOI: 10.1371/journal.pone.0005656. View

3.
Janghorbani M, Amini M . Patterns and predictors of long-term weight change in patients with type 2 diabetes mellitus. Ann Nutr Metab. 2009; 54(2):111-8. DOI: 10.1159/000209269. View

4.
Roumie C, Hung A, Greevy R, Grijalva C, Liu X, Murff H . Comparative effectiveness of sulfonylurea and metformin monotherapy on cardiovascular events in type 2 diabetes mellitus: a cohort study. Ann Intern Med. 2012; 157(9):601-10. PMC: 4667563. DOI: 10.7326/0003-4819-157-9-201211060-00003. View

5.
Williamson D . Weight loss and mortality in persons with type-2 diabetes mellitus: a review of the epidemiological evidence. Exp Clin Endocrinol Diabetes. 1998; 106 Suppl 2:14-21. DOI: 10.1055/s-0029-1212031. View